Northwest & Ethical Investments L.P. Veracyte, Inc. Transaction History
Northwest & Ethical Investments L.P.
- $3.69 Trillion
- Q1 2025
A detailed history of Northwest & Ethical Investments L.P. transactions in Veracyte, Inc. stock. As of the latest transaction made, Northwest & Ethical Investments L.P. holds 15,400 shares of VCYT stock, worth $416,262. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,400Holding current value
$416,262% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding VCYT
# of Institutions
306Shares Held
79.1MCall Options Held
15.5KPut Options Held
16.7K-
Vanguard Group Inc Valley Forge, PA8.26MShares$223 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$211 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.24MShares$142 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl3.94MShares$106 Million1.26% of portfolio
-
Wellington Management Group LLP Boston, MA3.85MShares$104 Million0.02% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $1.93B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...